Ignite Creation Date:
2025-12-24 @ 3:24 PM
Ignite Modification Date:
2026-01-04 @ 9:44 AM
Study NCT ID:
NCT01135992
Status:
COMPLETED
Last Update Posted:
2016-01-22
First Post:
2010-05-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-05-31
First Submit QC Date:
None
Study First Post Date:
2010-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-16
Results First Submit QC Date:
None
Results First Post Date:
2016-01-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-03-18
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-12-14
Last Update Post Date:
2016-01-22
Last Update Post Date Type:
ESTIMATED